CEACAM5 and familial pancreatic carcinoma: Although CA 19-9 has been widely recognized as a marker associated with metastatic disease in pancreatic cancer,13 the prognostic role of CEA in PDAC, particularly regarding its association with metastatic disease versus local progression, is less well established.